Giant Biogene Holding Co. Ltd., China’s largest supplier of collagen-based skincare products, has filed for a Hong Kong IPO, joining the growing list of Chinese companies seeking to tap into global capital through the financial hub as they shy away from increasingly problematic US listings.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
